Montelukast neuropsychiatric reaction — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: E — Advise prompt prescriber review and consider reporting the suspected reaction
Neuropsychiatric reactions are recognised with montelukast and require review. In this vignette, "Advise prompt prescriber review and consider reporting the suspected reaction" is the safest single best answer. The other options are less appropriate because they miss the key clinical risk, conflict with UK medicines guidance, or delay needed review.
Reference: BNF; MHRA Drug Safety Update